Clinical trial
Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial…
NCT00023894 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00023894 |
|---|---|
| Title | Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer |
| Official title | A Phase II Evaluation of Flavopiridol (NSC# 649890) in the Treatment of Recurrent or Persistent Endometrial Carcinoma |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Endometrial Cancer |
| Intervention type | Drug |
| Interventions | alvocidib |
| Start date | Jul 1, 2001 |
| Completion | Feb 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 24, 2013 |
| Countries | Australia, Canada, Norway, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: